Tempest Therapeutics (TPST) Other Non-Current Assets (2012 - 2026)

Tempest Therapeutics has disclosed Other Non-Current Assets across 15 years of filings, most recently posting $501000.0 for Q2 2026.

• In Q2 2026, Other Non-Current Assets fell 5.29% year-over-year to $501000.0; the TTM figure through Jun 2026 stood at $501000.0 (down 5.29% YoY), while the FY2025 annual figure was $517000.0, up 6.6% from the prior year.
• Other Non-Current Assets came in at $501000.0 for Q2 2026 at Tempest Therapeutics, down from $517000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $683000.0 in Q3 2022 to a low of $393000.0 in Q3 2023.
• Average Other Non-Current Assets over 5 years is $480764.7, with a median of $480000.0 recorded in 2022.
• Year-over-year, Other Non-Current Assets surged 509.82% in 2022 and tumbled 42.46% in 2023.
• Over 5 years, Other Non-Current Assets stood at $429000.0 in 2022, then climbed by 4.43% to $448000.0 in 2023, then advanced by 8.26% to $485000.0 in 2024, then increased by 6.6% to $517000.0 in 2025, then retreated by 3.09% to $501000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $501000.0 in Q2 2026, $517000.0 in Q4 2025, and $519000.0 in Q3 2025.